CAS 942195-55-3

TEGOPRAZAN

Description:

Tegoprazan is a novel potassium-competitive acid blocker (P-CAB) that is primarily used for the treatment of acid-related gastrointestinal disorders, such as gastroesophageal reflux disease (GERD). It functions by selectively inhibiting the gastric H+/K+-ATPase enzyme, which plays a crucial role in gastric acid secretion. This mechanism allows for rapid and sustained reduction of gastric acidity. Tegoprazan is characterized by its high potency, quick onset of action, and a favorable pharmacokinetic profile, which includes a relatively long half-life, allowing for once-daily dosing. Additionally, it has been shown to have a lower potential for drug interactions compared to traditional proton pump inhibitors (PPIs). The substance is typically administered orally and is well-tolerated, with a safety profile that includes common side effects associated with acid suppression therapies. Ongoing research continues to explore its efficacy and safety in various populations and conditions, further establishing its role in the management of acid-related disorders.

Synonyms:

• 1H-Benzimidazole-5-carboxamide, 7-[[(4S)-5,7-difluoro-3,4-dihydro-2H-1-benzopyran-4-yl]oxy]-N,N,2-trimethyl-
• 7-[[(4S)-5,7-difluoro-3,4-dihydro-2H-1-benzopyran-4-yl]oxy]-N,N,2-trimethyl-1H-benzimidazole-5-carboxamide
• CJ 12420
• Tegoprazan Emixustat HCL Hydrochloride
• Tegoprazan
• 7-[[(4S)-5,7-difluoro-3,4-dihydro-2H-chromen-4-yl]oxy]-N,N,2-trimethyl-3H-benzimidazole-5-carboxamide
• RQ-00000004
• RQ-4

Tegoprazan

CAS: 942195-55-3

Tegoprazan

Purity: ≥98%

Molecular weight: 387.38g/mol

Ref: 54-BUP09385

Tegoprazan-d6

CAS: 942195-55-3

Formula: C₂₀H₁₃D₆F₂N₃O₃

Molecular weight: 393.42

Ref: 4Z-T-252021

Tegoprazan

CAS: 942195-55-3

Formula: C₂₀H₁₉F₂N₃O₃

Molecular weight: 387.39

Ref: 4Z-T-252001

Tegoprazan

CAS: 942195-55-3

Tegoprazan is an orally active, highly selective gastric H+/K+-ATPase inhibitor.Cost-effective and quality-assured.

Formula: C₂₀H₁₉F₂N₃O₃

Purity: 98.22%

Color and Shape: Solid

Molecular weight: 387.38

Ref: TM-T17030

Tegoprazan

Controlled Product

CAS: 942195-55-3

Formula: C₂₀H₁₉F₂N₃O₃

Color and Shape: Neat

Molecular weight: 387.38

Ref: TR-T145030

Tegoprazan

CAS: 942195-55-3

Tegoprazan is an anti-gastric acid drug that is a proton pump inhibitor. It inhibits the production of gastric acid by inhibiting the H+, K+-ATPase enzyme (proton pump) in the gastric mucosa cells. Tegoprazan has dose-dependent effects and can be used for long-term treatment of diseases such as peptic ulcer, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. Tegoprazan does not show any serious side effects, but it may cause some adverse reactions, such as drug reactions or increased risk for developing stomach cancer. Tegoprazan also has antiplatelet properties and can be used to prevent blood clot formation in patients after coronary artery bypass grafting surgery.

Formula: C₂₀H₁₉F₂N₃O₃

Purity: Min. 95%

Molecular weight: 387.4 g/mol

Ref: 3D-SMB19555